LTRN

Lantern Pharma Inc.

Nasdaq· Pharmaceutical Preparations· Inc. TX· CIK 0001763950 Biotech & Drug Discovery

$0.6350 −0.01 (−0.94%)

Oct 23 4:00 PM ET · prev $0.6410

Market cap

$9.6M

Nano cap

Median target

$17.50

+2656% · range $10.00–25.00

Next earnings

Nov 11

in 16 days · EPS est. −$0.38

1 year

−84.3%

from $4.05 · Oct 27

30 days

−41.7%

from $1.09

52-week range

$0.6350–4.17

at the low

Avg volume 20D

339.9K

Oct 20 spike 1.88M

Short interest

🔒 Subscribers only

Insider net

+$200.0K

2 buyers · 0 sellers · 12 mo

New fund stakes

Q2 2026 13F · 0 exits

Filing reports

analyzed by SecBot

SecBot read BEARISH 8 reports · 90 days

Balance 4 bearish · 0 bullish · 1 mixed · 3 neutral oldest → newest, height = score

Avg score

·High conf. 8/8 ·Next Earnings date, Nov 11, 2026

Strongest BEARISH Lantern Pharma's 2026 definitive proxy statement schedules seven proposals for the December 1, 2026 annual…

All reports →

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

Signal stack

Where each data set points today.

InsidersBULLISH

2 insiders bought $200.0K at an average $2.06. No open-market sales. Price is 69% below their cost.
InstitutionsMIXED

Q2 2026: 4 added (0 new), 2 trimmed or exited.
TrendDOWNTREND

57% below its 50-day average. New closing low $0.6350 on Oct 23.

Who's buying

13F· Q2 2026

new positions

exits

Fund	Move	Shares	Value
VANGUARD CAPITAL MANAGEMENT LLC	ADD	425,118	$1.8M
RENAISSANCE TECHNOLOGIES LLC	DOUBLED	291,039	$1.2M
BlackRock, Inc.	TRIM	22,350	$93.2K
DIMENSIONAL FUND ADVISORS LP	TRIM	16,725	$69.7K
UBS Group AG	ADD	16,632	$69.4K
SIMPLEX TRADING, LLC	DOUBLED	2,337	$9.7K
NewEdge Advisors, LLC	TRIM	27,399	$37.5K
SIMPLEX TRADING, LLC	NEAR_EXIT	107	$146.00

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

last action Apr 2025

12-month targets · 2 analysts

$0.6350 $10.00 $17.50 $25.00

Price is below the lowest target. Median implies +2656%.Targets as of Oct 27, 2026.

Recent actions

Date	Firm	Action	Rating
Apr 2, 2025	Lake Street INITIATE	INITIATE	Buy
Apr 25, 2024	HC Wainwright & Co. REITERATE	REITERATE	Neutral
Aug 10, 2023	EF Hutton REITERATE	REITERATE	Buy
Jun 26, 2023	EF Hutton MAINTAIN	MAINTAIN	Buy
May 18, 2023	HC Wainwright & Co. INITIATE	INITIATE	Neutral
Mar 21, 2023	EF Hutton REITERATE	REITERATE	Buy

Insider ledger

Form 4

$200.0K

bought · 2 insiders

sold · 0 insiders

−69.2%

vs their $2.06 cost

Date	Insider	Type	Value
May 12, 2026	Schalop Lee Troy Director	BUY	48,544 sh
May 12, 2026	KEYSER D JEFFREY Director	BUY	$100.0K
May 12, 2026	KEYSER D JEFFREY Director	BUY	48,544 sh
May 12, 2026	Schalop Lee Troy Director	BUY	$100.0K

Earnings setup

Estimates

Nov 11

reports in 16 days

−$0.38

EPS estimate, this quarter

Current-quarter EPS estimate

$0.000

90d

$0.000

60d

−$0.380

30d

−$0.380

Now

Period	EPS est.	Range	30D rev.	Revenue
Current Q	-$0.38	-$0.38–-$0.38	+0.0%	$0.00
Next Q	-$0.44	-$0.44–-$0.44	+0.0%	$0.00
Next FY	-$2.02	-$2.02–-$2.02	+0.0%	$0.00
Current FY	-$1.51	-$1.51–-$1.51	+0.0%	$0.00